Official journal for @my_UEG, publishing high quality research in gastroenterology, hepatology and related fields. Free open access. NEW Impact factor: 6.7

Vienna, Austria
Joined March 2019
Community area now!! AI in publishing, YAY or NEY and if yes HOW, WHAT and WHEN??? @my_ueg #ueg2026
1
3
317
⏱️Immediate necrosectomy is not superior to an on-demand in #NecrotizingPancreatitis 🔸No clear benefit in clinical/technical success 🔸Adverse events & mortality similar 🔸Fewer stent migrations overall, not in RCT-only analysis 📖 #OpenAccess 👉 bit.ly/4jMrdpi
1
9
1
15
1,194
🧩Primary care #IBS carries a high symptom & psychosocial burden 🔸70% met Rome IV criteria; 77% had moderate-severe symptoms 🔸IBS-D & IBS-M were most common 🔸Rome IV-positive & IBS-M had greater symptom & psychosocial burden 📖 #OpenAccess 👉 bit.ly/4yGI5CP
1
4
8
852
🧬Familial/germline #PancreaticCancer risk is not linked to higher pancreatic fat 🔸AI matched expert radiologists closely 🔸Pancreatic fat: 25.8% vs 26.9% in controls 🔸Fat was linked to age, male sex, diabetes & BMI 📖 #OpenAccess 👉 bit.ly/47ehhxw @my_ueg
1
6
8
690
Pancreatic enzyme needs vary by aetiology. EURO-PEI (n=1,015): highest optimised doses after pancreatectomy & in pancreatic cancer. 46.9% of goal achievers needed doses above usual starting doses. Individualise PERT. doi.org/10.1002/ueg2.70282
1
4
17
1,017
Pancreatic enzyme needs vary by aetiology. EURO-PEI (n=1,015): highest optimised doses after pancreatectomy & in pancreatic cancer. 46.9% of goal achievers needed doses above usual starting doses. Individualise PERT. doi.org/10.1002/ueg2.70282
1
6
8
1,082
🏆 Introducing the @UEGJournal​​ Most Cited Article Award! Congratulations to the authors of articles 👏 🔹 Abdulbaqi Al-Toma 🔗 bit.ly/4d9lI06 🔹 Rogier Voermans 🔗 bit.ly/4jwRyYk 🔹 Karn Wijarnpreecha and @PojsakornDan​ 🔗 bit.ly/4lCn18Q
5
1
10
1,381
UEGJ retweeted
🧬 #Microlithiasis may trigger acute #pancreatitis via #NLRP3-driven papillitis 🔸Papillary biopsies showed ↑inflammation & NLRP3 🔸Cholesterol/bilirubinate crystals activated macrophage NLRP3 🔸Supports inflammation as a trigger 📖 #OpenAccess 👉 bit.ly/4vklLg9
1
11
1
30
2,721
UEGJ retweeted
🧭 #Ustekinumab offers a safety advantage after #vedolizumab failure in #UC 🔸 Similar remission rates with infliximab, anti-TNF SC & ustekinumab 🔸 Fewer adverse events and treatment discontinuations with ustekinumab 📖 #OpenAccess 👉 bit.ly/3SctjmK @my_ueg
2
23
1
55
3,804
UEGJ retweeted
💧Lactated Ringer’s remains the reference fluid for post-ERCP pancreatitis (#PEP) prevention 🔸PEP: 12.4% with lactated Ringer’s vs 11.5% acetate fluid 🔸No severe PEP or fluid overload 🔸Two-thirds completed hydration within 4h 📖 #OpenAccess 👉 bit.ly/4e5KKxi
2
16
27
2,054
💧Lactated Ringer’s remains the reference fluid for post-ERCP pancreatitis (#PEP) prevention 🔸PEP: 12.4% with lactated Ringer’s vs 11.5% acetate fluid 🔸No severe PEP or fluid overload 🔸Two-thirds completed hydration within 4h 📖 #OpenAccess 👉 bit.ly/4e5KKxi
2
16
27
2,054
🧭 International consensus set standards for EUS-guided choledochoduodenostomy with LAMS 🔸Preferred over percutaneous drainage after failed ERCP 🔸CBD ≥15 mm preferred 🔸Oral intake within 24h after uncomplicated procedures 📖 #OpenAccess 👉 bit.ly/4jlz1OG
1
21
52
2,745
🧠 Globus commonly overlaps with other #DGBI 🔸Global prevalence: 0.75% 🔸49% had non-esophageal DGBI 🔸Only 17.4% reported frequent heartburn 🔸60.5% had anxiety and/or depression 📖 #OpenAccess 👉 bit.ly/3VaivqS @my_ueg
1
7
12
1,027